ATE247976T1 - 10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel - Google Patents

10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel

Info

Publication number
ATE247976T1
ATE247976T1 AT00945698T AT00945698T ATE247976T1 AT E247976 T1 ATE247976 T1 AT E247976T1 AT 00945698 T AT00945698 T AT 00945698T AT 00945698 T AT00945698 T AT 00945698T AT E247976 T1 ATE247976 T1 AT E247976T1
Authority
AT
Austria
Prior art keywords
therapeutic agent
formyltetrahydrofolate dehydrogenase
formyltetrahydrofolate
dehydrogenase
agent
Prior art date
Application number
AT00945698T
Other languages
English (en)
Inventor
Alberto Bartorelli
Original Assignee
Pharmaproducts Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT1999MI001243 external-priority patent/IT1312341B1/it
Priority claimed from IT1999MI002197 external-priority patent/IT1314197B1/it
Application filed by Pharmaproducts Uk Ltd filed Critical Pharmaproducts Uk Ltd
Application granted granted Critical
Publication of ATE247976T1 publication Critical patent/ATE247976T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • C12Y105/01006—Formyltetrahydrofolate dehydrogenase (1.5.1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT00945698T 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel ATE247976T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI001243 IT1312341B1 (it) 1999-06-03 1999-06-03 Proteina estraibile da fegato di mammiferi ad attivita' antitumorale.
IT1999MI002197 IT1314197B1 (it) 1999-10-20 1999-10-20 10-formiltetraidrofolato deidrogenasi come agente terapeutico.
PCT/EP2000/005066 WO2000074711A2 (en) 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase as therapeutical agent

Publications (1)

Publication Number Publication Date
ATE247976T1 true ATE247976T1 (de) 2003-09-15

Family

ID=26331660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945698T ATE247976T1 (de) 1999-06-03 2000-06-02 10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel

Country Status (7)

Country Link
EP (1) EP1181046B1 (de)
JP (1) JP2003501398A (de)
AT (1) ATE247976T1 (de)
AU (1) AU5969500A (de)
DE (1) DE60004819T2 (de)
ES (1) ES2204649T3 (de)
WO (1) WO2000074711A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115166067B (zh) * 2022-05-26 2023-12-26 中国农业科学院北京畜牧兽医研究所 用于相对定量分析猪10-甲酰基四氢叶酸脱氢酶aldh1l1的肽段组合物及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1185862A2 (de) * 1999-06-01 2002-03-13 Proteome Sciences Plc Verfahren und zusammensetzungen bezüglich insulinresistenz-erkrankungen

Also Published As

Publication number Publication date
AU5969500A (en) 2000-12-28
WO2000074711A3 (en) 2001-07-26
DE60004819D1 (de) 2003-10-02
ES2204649T3 (es) 2004-05-01
EP1181046A2 (de) 2002-02-27
JP2003501398A (ja) 2003-01-14
EP1181046B1 (de) 2003-08-27
DE60004819T2 (de) 2004-07-01
WO2000074711A2 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
NO20021701L (no) Fremgangsmåte for fremstilling av et konjugat av polyglutamat og et terapeutisk middel
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
EP1352896A3 (de) Adamantanderivate zur Behandlung von entzündlichen, immunologischen und kardiovaskulären Erkrankungen
WO2004021968A3 (en) Solution for ungual application
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
NO20015991D0 (no) Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
WO2001028494A3 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
MXPA03010761A (es) Combinaciones farmaceuticas.
IL155263A0 (en) Pharmaceutical solutions of modafinil compounds
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
PL369148A1 (en) Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
WO2003008637A3 (en) Use of genotyping in the individualization of therapy
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
MXPA04001912A (es) Aminobenzofenonas novedosas.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
DE60004819D1 (de) 10-formyltetrahydrofolate dehydrogenase als therapeutischen mittel
WO2000069841A3 (en) Benzofuranylaminoalcohols
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
HUP0302984A2 (hu) Buprenorphin felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties